| __timestamp | ADMA Biologics, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 10811000 |
| Thursday, January 1, 2015 | 6745968 | 33001000 |
| Friday, January 1, 2016 | 8494742 | 64936000 |
| Sunday, January 1, 2017 | 18092835 | 99909000 |
| Monday, January 1, 2018 | 22502922 | 127724000 |
| Tuesday, January 1, 2019 | 25910757 | 161524000 |
| Wednesday, January 1, 2020 | 35050817 | 182933000 |
| Friday, January 1, 2021 | 42896889 | 219982000 |
| Saturday, January 1, 2022 | 52458024 | 278139000 |
| Sunday, January 1, 2023 | 59020000 | 309799000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing expenses is crucial for sustained growth. This analysis compares the Selling, General, and Administrative (SG&A) expenses of ADMA Biologics, Inc. and Ultragenyx Pharmaceutical Inc. from 2014 to 2023. Over this period, Ultragenyx's SG&A expenses surged by approximately 2,765%, starting from $10.8 million in 2014 to a staggering $310 million in 2023. In contrast, ADMA Biologics saw a more modest increase of around 1,124%, with expenses rising from $4.8 million to $59 million. This stark difference highlights Ultragenyx's aggressive expansion strategy, while ADMA Biologics appears to be more conservative in its spending. Understanding these trends provides valuable insights into each company's operational strategies and market positioning. As the biotech industry continues to evolve, monitoring such financial metrics will be key to predicting future growth trajectories.
Summit Therapeutics Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Ultragenyx Pharmaceutical Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Ultragenyx Pharmaceutical Inc.
Exelixis, Inc. or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Blueprint Medicines Corporation and Ultragenyx Pharmaceutical Inc.: SG&A Spending Patterns Compared
Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Verona Pharma plc vs Ultragenyx Pharmaceutical Inc.
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
ADMA Biologics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing ADMA Biologics, Inc. and BioCryst Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.
Ultragenyx Pharmaceutical Inc. and Novavax, Inc.: SG&A Spending Patterns Compared